Upendra A. Argikar

2.1k total citations
55 papers, 1.2k citations indexed

About

Upendra A. Argikar is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Upendra A. Argikar has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 27 papers in Pharmacology and 13 papers in Oncology. Recurrent topics in Upendra A. Argikar's work include Pharmacogenetics and Drug Metabolism (25 papers), Drug Transport and Resistance Mechanisms (11 papers) and Metabolomics and Mass Spectrometry Studies (7 papers). Upendra A. Argikar is often cited by papers focused on Pharmacogenetics and Drug Metabolism (25 papers), Drug Transport and Resistance Mechanisms (11 papers) and Metabolomics and Mass Spectrometry Studies (7 papers). Upendra A. Argikar collaborates with scholars based in United States, Switzerland and China. Upendra A. Argikar's co-authors include Rory P. Remmel, Mithat Gunduz, Swati Nagar, Shawn Harriman, Nigel J. Waters, Christine E. Dunne, Bruce Amiot, Scott L. Nyberg, Piero Rinaldo and Robert H. Tukey and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and The FASEB Journal.

In The Last Decade

Upendra A. Argikar

51 papers receiving 1.2k citations

Peers

Countries citing papers authored by Upendra A. Argikar

Since Specialization

Citations

This map shows the geographic impact of Upendra A. Argikar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Upendra A. Argikar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Upendra A. Argikar more than expected).

Fields of papers citing papers by Upendra A. Argikar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Upendra A. Argikar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Upendra A. Argikar. The network helps show where Upendra A. Argikar may publish in the future.

Co-authorship network of co-authors of Upendra A. Argikar

This figure shows the co-authorship network connecting the top 25 collaborators of Upendra A. Argikar. A scholar is included among the top collaborators of Upendra A. Argikar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Upendra A. Argikar. Upendra A. Argikar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biotransformation research advances – 2024 year in review 2025 ·Drug Metabolism Reviews ·Lionel Cheruzel, Upendra A. Argikar, Pietro Brunetti, Maria Chatzopoulou, Sungjoon Cho, (unknown), (unknown), Kevin M. Johnson, Valerie M. Kramlinger, Joyce Liu, Bin Ma, (unknown), (unknown), (unknown), (unknown), (unknown), S. Cyrus Khojasteh	0
2	Clinical Significance of Drug–Drug Interaction Studies During Therapeutic Peptide Drug Development: Follow‐Up Investigation of Therapeutic Peptides Approved Between 2021 and 2024 2025 ·Clinical and Translational Science ·(unknown), Upendra A. Argikar, Constanze Hilgendorf, Hilmar Schiller, (unknown), Kenichi Umehara, (unknown)	1
3	Biotransformation research advances – 2023 year in review 2024 ·Drug Metabolism Reviews ·S. Cyrus Khojasteh, Upendra A. Argikar, Maria Chatzopoulou, Lionel Cheruzel, Sungjoon Cho, (unknown), Kevin M. Johnson, Amit S. Kalgutkar, Joyce Liu, Bin Ma, (unknown), Jessica A. Rowley, (unknown), Shuai Wang	0
4	Industry Perspective on Therapeutic Peptide Drug–Drug Interaction Assessments During Drug Development: A European Federation of Pharmaceutical Industries and Associations White Paper 2023 ·Clinical Pharmacology & Therapeutics ·(unknown), Upendra A. Argikar, Kari R. Fonseca, Constanze Hilgendorf, (unknown), (unknown), Hilmar Schiller, Anders Sonesson, Kenichi Umehara, Kai Wang	15
5	Biotransformation novel advances – 2021 year in review 2022 ·Drug Metabolism Reviews ·S. Cyrus Khojasteh, Upendra A. Argikar, Sungjoon Cho, (unknown), (unknown), Kevin M. Johnson, Amit S. Kalgutkar, Lloyd King, (unknown), (unknown), Shuai Wang, Cong Wei, Donglu Zhang, Klarissa D. Jackson	3
6	Novel advances in biotransformation and bioactivation research – 2020 year in review 2021 ·Drug Metabolism Reviews ·S. Cyrus Khojasteh, Upendra A. Argikar, James P. Driscoll, (unknown), Lloyd King, Klarissa D. Jackson, Wenying Jian, Amit S. Kalgutkar, Grover P. Miller, Valerie M. Kramlinger, Ivonne M.C.M. Rietjens, Aaron M. Teitelbaum, (unknown), Cong Wei	6
7	Comparative Proteomics Analysis of the Postmitochondrial Supernatant Fraction of Human Lens-Free Whole Eye and Liver 2021 ·Drug Metabolism and Disposition ·(unknown), Abdul Basit, Upendra A. Argikar, (unknown), Saranjit Singh, Bhagwat Prasad	6
8	Understanding metabolism related differences in ocular efficacy of MGV354 2020 ·Xenobiotica ·(unknown), Upendra A. Argikar, Christopher M. Adams, Ganesh Prasanna, Takeru Ehara, (unknown), Chris Breen, Muneto Mogi	2
9	Implications for Metabolite Quantification by Mass Spectrometry in the Absence of Authentic Standards 2017 ·Drug Metabolism and Disposition ·Panos Hatsis, Nigel J. Waters, Upendra A. Argikar	22
10	Ocular Metabolism of Levobunolol: Historic and Emerging Metabolic Pathways 2016 ·Drug Metabolism and Disposition ·Upendra A. Argikar, (unknown), Christine E. Dunne, Chitra Saran, (unknown), Mehmet Gündüz	12
11	Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance 2016 ·The AAPS Journal ·Upendra A. Argikar, Philip M. Potter, J. Matthew Hutzler, Punit H. Marathe	69
12	Metabolism of Bromopride in Mouse, Rat, Rabbit, Dog, Monkey, and Human Hepatocytes 2013 ·Drug Metabolism and Pharmacokinetics ·Christine E. Dunne, (unknown), Upendra A. Argikar	10
13	Comprehensive Assessment of Human Pharmacokinetic Prediction Based on In Vivo Animal Pharmacokinetic Data, Part 2: Clearance 2012 ·The Journal of Clinical Pharmacology ·Franco Lombardo, Nigel J. Waters, Upendra A. Argikar, Michelle K. Dennehy, Jenny Zhan, Mithat Gunduz, Shawn Harriman, Giuliano Berellini, (unknown), R. Scott Obach	72
14	Comprehensive Assessment of Human Pharmacokinetic Prediction Based on In Vivo Animal Pharmacokinetic Data, Part 1: Volume of Distribution at Steady State 2012 ·The Journal of Clinical Pharmacology ·Franco Lombardo, Nigel J. Waters, Upendra A. Argikar, Michelle K. Dennehy, Jenny Zhan, Mithat Gunduz, Shawn Harriman, Giuliano Berellini, (unknown), R. Scott Obach	57
15	Oxidative ipso Substitution of 2,4-Difluoro-benzylphthalazines: Identification of a Rare Stable Quinone Methide and Subsequent GSH Conjugate 2012 ·Drug Metabolism and Disposition ·Mithat Gunduz, Upendra A. Argikar, Amin Kamel, (unknown), (unknown), (unknown), Franco Lombardo, Shawn Harriman	10
16	Identification of Novel Metoclopramide Metabolites in Humans: In Vitro and In Vivo Studies 2010 ·Drug Metabolism and Disposition ·Upendra A. Argikar, Javier Gómez‐Román, (unknown), Henry P. Parkman, Swati Nagar	24
17	Variation in glucuronidation of lamotrigine in human liver microsomes 2009 ·Xenobiotica ·Upendra A. Argikar, Rory P. Remmel	58
18	Identification of a Novel N-Carbamoyl Glucuronide: In Vitro, In Vivo, and Mechanistic Studies 2009 ·Drug Metabolism and Disposition ·Mithat Gunduz, Upendra A. Argikar, Daniel K. Baeschlin, Suzie A. Ferreira, Vinayak Hosagrahara, Shawn Harriman	28
19	Effect of Aging on Glucuronidation of Valproic Acid in Human Liver Microsomes and the Role of UDP-Glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10 2008 ·Drug Metabolism and Disposition ·Upendra A. Argikar, Rory P. Remmel	105
20	Rapid, large-scale formation of porcine hepatocyte spheroids in a novel spheroid reservoir bioartificial liver 2005 ·Liver Transplantation ·Scott L. Nyberg, (unknown), Bruce Amiot, Upendra A. Argikar, Rory P. Remmel, Piero Rinaldo	112

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact